Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if a naturally-occurring hormone called erythropoietin
changes the action of platelets in the blood. Erythropoietin is made by the kidneys to
stimulate red blood cell production to prevent anemia. Platelets are small cells in the blood
that help clot blood in case of injury. Platelets also sometimes form blood clots in blood
vessels that may cause heart attacks. This study is trying to determine whether
erythropoietin increases the clotting action of platelets. Information on erythropoietin in
healthy subjects may eventually help in the treatment of patients with heart attacks.